Redirecting Europe’s AI Industrial Policy: From Competitiveness to Public Interest
Our latest report identifies key insights for AI regulation across the development cycle, drawing on lessons from pharmaceutical regulation.
Our latest report identifies key insights for AI regulation across the development cycle, drawing on lessons from pharmaceutical regulation.
Researchers hope to investigate IDO1 inhibitors in human trials for Alzheimer’s disease in the near future.
Team members describe what went into making and publishing 2024’s most engaging images and multimedia
Following a historic victory at the polls, what will a second Trump term mean for America’s AI future?
Trump’s shakeups, risks from avian flu, and peak carbon emissions could produce big stories
A new study shows that intelligence is best predicted by global brain connectivity, not just specific regions, indicating a more holistic neural basis for cognition.…
Ishikawa Komuro Lab’s high-speed robot hand performing impressive acts of dexterity and skillful manipulation. For more information, see Hizook.com — http:…
Team members describe what went into making and publishing 2024’s most engaging images and multimedia
The past year has been a complicated one for health insurers, and our top stories of the year reflect the headwinds many companies faced and…
For seven years, the cardiac surgical team has leveraged computational fluid dynamics software to provide consistent preoperative planning for pediatric congenital heart disease patients and…
As one telemedicine CEO looks to the year ahead, he predicts RPM will improve outcomes for congestive heart failure patients and help manage those on…